| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Chemed Corporation$517.63
+8.29 (+1.63%)
Market Cap
5.31 B
EPS
18.45
P/E Ratio
21.01 $
Value Trade
113.28 M
SEC Financials
Q1 2026Dilution Risk
Revenue
657.51 M
Operating CF
88.22 M
Total Assets
1.54 B
Total Liabilities
687.82 M
Equity
847.99 M
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
16.86 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Apr 28, 2026
Overview
Volume
198.19 K
52 Week Range
365.21 - 604.91
% held by Insiders
1.85 %
% held by Institutions
103.3 %
Enterprise Value
5.39 B
Total Shares
13.27 M
Short %
4.34 %
Float Shares
13.02 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Chemed Corporation
1Total events
1Upcoming
0Tier-1 (high impact)
2026 – 2026Coverage
Upcoming catalysts 1
TBD
T2Quarterly Update
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in CHE
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
CHE Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-12-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-12-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-12-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-CHE
Jul 28, 2026▲ +1.6%today
Chemed Reports Second-Quarter 2026 Results
Chemed Corporation reported strong financial results for the second quarter of 2026, with revenue increasing by 8.8% to $673.3 million and GAAP diluted earnings per share rising by 43.7%. The VITAS segment experienced significant growth, particularly in net patient revenue and admissions. However, the Roto-Rooter segment faced challenges with flat adjusted EBITDA and a decline in water restoration revenue. The company has revised its full-year earnings guidance upward, reflecting improved performance.
Read more →-CHE
Jul 1, 2026Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
Chemed Corporation will announce its second quarter financial results on July 28, 2026, after market close. A conference call to discuss these results will take place on July 29, 2026, at 10 a.m. ET. Participants can join via webcast or teleconference, and a replay will be available shortly after the call.
Read more →-CHE
May 13, 2026Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
Chemed Corporation announced its participation in the RBC Capital Markets Global Healthcare Conference on May 20, 2026. The presentation will take place at 8:30 a.m. ET at The InterContinental New York Barclay Hotel. An audio webcast will be available on the company's website, with a replay accessible for 90 days.
Read more →-CHE
May 5, 2026Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
Chemed Corporation will present at the Bank of America Securities 2026 Health Care Conference on May 12, 2026. The event will take place at the Encore at the Wynn Las Vegas and will be available via live webcast. Chemed operates VITAS Healthcare and Roto-Rooter, leaders in hospice care and plumbing services, respectively.
Read more →-CHE
Apr 23, 2026Michael D. Witzeman (513) 762- 6714  Chemed Reports First-Quarter 2026 Results  Full-Year Guidance Increased Due To: · Strong VITAS Performance · Re-purchase of 500,000 Shares in the Qu
Chemed Corporation reported its first-quarter 2026 results, showing a revenue increase in its VITAS segment and notable growth in admissions. The company also raised its full-year guidance due to stronger-than-anticipated performance, leading to improved revenue and adjusted EBITDA projections. In contrast, Roto-Rooter faced a slight revenue decline attributed to service disruptions and higher marketing costs. The company remains optimistic about future growth, highlighted by a significant share repurchase program.
Read more →-CHE
Apr 13, 2026Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
Chemed Corporation has announced a five-year amended and restated credit agreement worth $450 million. This agreement includes a revolving credit facility and an option to expand by an additional $250 million. The interest rate is tied to the secured overnight financing rate (SOFR). Chemed operates two subsidiaries, VITAS Healthcare and Roto-Rooter.
Read more →-CHE
Apr 13, 2026ITEM 991 Press Release for Amended Restated Credit Facility  CONTACT: Michael D. Witzeman FOR IMMEDIATE RELEASE (513) 762-6714  Chemed Corporation Announces a Five-Year $450 Million Amended and Restated C
Chemed Corporation announced an Amended and Restated Credit Agreement, securing a five-year revolving credit facility worth $450 million. The agreement includes a $100 million allocation for letters of credit and features a floating interest rate based on the secured overnight financing rate (SOFR). Additionally, Chemed can expand the facility by up to $250 million, enhancing its financial flexibility. The company operates two subsidiaries, VITAS Healthcare and Roto-Rooter, emphasizing its diversified business model. Investors are cautioned regarding the inherent risks associated with forward-looking statements about Chemed's performance.
Read more →-CHE
Feb 26, 2026▼ -15%on this news
Chemed Reports Fourth-Quarter 2025 Results
Chemed Corporation reported its fourth-quarter results for 2025, showing mixed performance across its segments. VITAS Healthcare saw a 1.9% increase in revenue, driven by higher admissions and Medicare reimbursement rates, while Roto-Rooter experienced a revenue decline of 3.7%. The company remains debt-free and has plans for revenue growth in 2026, despite challenges in the Roto-Rooter segment.
Read more →-CHE
Feb 25, 2026Michael D. Witzeman (513) 762- 6714  Chemed Reports Fourth-Quarter 2025 Results  CINCINNATI
Chemed Corporation reported its fourth-quarter financial results for 2025, showing a 1.9% increase in VITAS revenue year-over-year, driven by increased days-of-care and higher Medicare reimbursement rates. Total VITAS admissions also grew by 6.0%, although the VITAS segment's gross margin decreased by 150 basis points compared to the previous year. Roto-Rooter, however, faced a decline in revenues, down 3.7% from last year, with a notable drop in its adjusted EBITDA margin. Looking forward, Chemed projected revenue growth for both VITAS and Roto-Rooter in 2026 despite the challenges faced in the previous quarter.
Read more →-CHE
Jan 5, 2026Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
Chemed Corporation will release its fourth-quarter earnings for 2025 on February 25, 2026. A conference call is scheduled for February 26, 2026, to discuss the results and provide business updates. Investors can access the call via webcast or teleconference, with a replay available shortly after the event.
Read more →-CHE
Oct 28, 2025Michael D. Witzeman (513) 762- 6714  Chemed Reports Third-Quarter 2025 Results  CINCINNATI
Chemed Corporation reported its third-quarter 2025 results, showing a positive 4.2% revenue increase for its VITAS segment, driven by higher admissions. Roto-Rooter also experienced a modest revenue rise of 1.1%. However, the company faced challenges with declining gross margins and adjusted EBITDA for both segments. Chemed reiterated its guidance for the year, projecting earnings per share between $22.00 and $22.30, contingent on Medicare-related conditions.
Read more →-CHE
Jul 29, 2025Michael D. Witzeman (513) 762- 6714  Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure   CINCINNATI
Chemed Corporation reported its second-quarter 2025 results, highlighting a 5.8% increase in VITAS net revenue, driven by admissions and Medicare reimbursement rate improvements. However, the company revised its full-year earnings guidance downwards significantly, attributing this to projected Medicare Cap billing limitations and weaker admissions in Florida. Additionally, the departure of CEO Nicholas M. Westfall, who will stay until December for a transition, adds to the company's uncertainties. Despite these challenges, Chemed maintains a strong cash position and is actively continuing its share repurchase program.
Read more →-CHE
Jun 27, 2025Michael D. Witzeman FOR IMMEDIATE RELEASE (513) 762-6714  Chemed To Report Second-Quarter 2025 Earnings
Chemed Corporation plans to report its second-quarter 2025 earnings on July 29, 2025. The announcement includes insights into its VITAS subsidiary, which is expecting a Medicare Cap revenue limitation due to weaker admissions than projected in Florida. However, VITAS has received a Certificate of Need to expand into Pinellas County, indicating potential for future growth. Additionally, Roto-Rooter has experienced unexpected weakness in its residential services, contrasting with improving trends in its commercial segment.
Read more →-CHE
Apr 23, 2025Michael D. Witzeman (513) 762- 6714  Chemed Reports First-Quarter 2025 Results   CINCINNATI
Chemed Corporation reported strong first-quarter results for 2025, with VITAS segment revenues increasing by 15.1% year-over-year. The company attributed $11.5 million to $12.5 million in revenue to the recent acquisition of Covenant Health's hospice assets. Roto-Rooter, while generating overall increased revenue, faced challenges with declines in certain service areas. The company maintains a robust cash position with no debt and plans to provide updated earnings guidance later in the year.
Read more →-CHE
Feb 26, 2025Michael D. Witzeman (513) 762- 6714  Chemed Reports Fourth-Quarter 2024 Results  CINCINNATI
Chemed Corporation reported its fourth-quarter 2024 financial results, noting a 17.4% revenue increase in its VITAS segment while Roto-Rooter saw a 2.9% decline. The VITAS acquisition of Covenant Health contributed approximately $11 million to revenue, resulting in a modest net income increase. Adjusted EBITDA for VITAS rose by 11.8%, but the overall gross margin decreased slightly compared to last year. Admissions for VITAS were negatively impacted by recent hurricanes, estimated to have affected around 150-175 patients.
Read more →-CHE
Oct 29, 2024Michael D. Witzeman (513) 762- 6714  Chemed Reports Third -Quarter 2024 Results  CINCINNATI
Chemed Corporation reported its third-quarter 2024 financial results, highlighting a 17.3% increase in VITAS revenue compared to the previous year. The company also noted challenges in its Roto-Rooter segment, which saw a 6.9% decline in quarterly revenue. Despite environmental impacts from Hurricane Helene causing a temporary slowdown in patient admissions, Chemed maintained a strong cash position without debt. The company reaffirmed its earnings guidance for 2024, indicating a positive outlook amidst challenges.
Read more →-CHE
Jul 24, 2024Michael D. Witzeman (513) 762- 6714  Chemed Reports Second-Quarter 2024 Results  CINCINNATI
Chemed Corporation has reported its financial results for the second quarter of 2024, highlighting a significant revenue increase in its VITAS segment, attributed to an acquisition and improved operational metrics. The company anticipates a notable contribution from the recently acquired Covenant Health assets, projecting a continued positive trend for VITAS. However, Roto-Rooter faced revenue declines in both commercial and residential sectors, which the company expects to persist into 2024. Adjusted EBITDA from VITAS saw a substantial increase, further strengthening Chemed's financial outlook.
Read more →-CHE
Apr 24, 2024Michael D. Witzeman (513) 762- 6714  Chemed Reports First-Quarter 2024 Results  CINCINNATI
Chemed Corporation reported its financial results for the first quarter of 2024, showcasing a strong performance in its VITAS Healthcare segment with a 14.0% increase in net revenue. The acquisition of hospice assets from Covenant Health for $85 million further underscores the company's strategic growth initiatives. However, the Roto-Rooter segment experienced a revenue decline of 5.8%, primarily attributed to reduced demand in commercial services. Adjusted EBITDA for the quarter saw an impressive rise of 67.2%, reflecting robust operational efficiencies.
Read more →-CHE
Mar 13, 2024 CONTACT: Michael D. Witzeman (513) 762- 6 714   VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama  CINCINNATI
VITAS Healthcare Corporation, a subsidiary of Chemed Corporation, has announced its agreement to acquire hospice operations and an assisted living facility from Covenant Care for $85 million. The deal encompasses key markets in Florida and Alabama, and is expected to close in the second quarter pending regulatory approvals. Both parties express enthusiasm about the shared mission to improve patient care, particularly in hospice and palliative services. The acquisition aims to enhance the quality of care while expanding the reach of both organizations in their respective communities.
Read more →-CHE
Feb 27, 2024Michael D. Witzeman (513) 762- 6714  Chemed Reports Fourth -Quarter 2023 Results   CINCINNATI
Chemed Corporation reported its fourth-quarter results for 2023, showing a robust increase in revenue for its VITAS Healthcare segment, which rose by 13.6%. Adjusted EBITDA for this segment also notably increased by 61.6%. However, the plumbing subsidiary Roto-Rooter faced revenue challenges, experiencing a 1.1% decrease quarter-over-quarter. Looking ahead, Chemed expects continued growth for VITAS and a modest revenue increase for Roto-Rooter in 2024.
Read more →-CHE
Dec 18, 2023 CONTACT: Michael D. Witzeman (513) 762- 6 714   Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO  CINCINNATI
Chemed Corporation has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams. Witzeman, who currently serves as Vice President and Controller, has been with Chemed since 2005 and brings significant experience in financial management. His appointment is seen as a move to ensure a smooth transition and continuity in the company’s financial operations. Chemed operates VITAS Healthcare and Roto-Rooter, leading companies in hospice care and plumbing services, respectively.
Read more →-CHE
Nov 3, 2023 CONTACT: Michael D. Witzeman (513) 762- 6 714   Chemed Corporation Announces the Retirement of David P. Williams  CINCINNATI
Chemed Corporation announced the retirement of David P. Williams, its Executive Vice President and Chief Financial Officer, effective December 31, 2023. Williams has been a key figure in the company for over thirty years, contributing to its substantial growth and financial management. He will continue to assist Chemed during the transition and provide guidance to the executive team and the Board of Directors. His legacy includes his leadership in various roles within Chemed and its subsidiaries.
Read more →-CHE
Oct 25, 2023David P. William s (513) 762-6901  Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance  CINCINNATI
Chemed Corporation reported its third-quarter results for 2023, showcasing a 12.5% increase in net revenue for its VITAS segment. It has revised its full-year earnings guidance upwards due to strong operational performance, particularly in adjusted EBITDA, which rose significantly. However, there are concerns regarding Roto-Rooter's profitability and the financial impact of the Retention Program on overall margins. The company also maintains a solid financial position with no debt and ample liquidity.
Read more →-CHE
Jul 26, 2023David P. William s (513) 762-6901 Chemed Reports Second-Quarter 2023 Results  CINCINNATI
Chemed Corporation reported its second-quarter financial results for 2023, highlighting a 7.8% increase in VITAS's net revenue, largely driven by a 6.2% rise in days-of-care. Despite revenue growth, adjusted EBITDA margins showed a decline due to sequestration effects and hiring costs. Roto-Rooter faced a minor revenue decline, though its commercial sector saw some revenue growth. The company continues to maintain a solid cash position, with no current debt and ongoing share buybacks.
Read more →-CHE
Apr 26, 2023xFEFF; CONTACT: David P. William s (513) 762-6901 Chemed Reports First-Quarter 2023 Results  CINCINNATI
Chemed Corporation released its financial results for the first quarter of 2023, reporting mixed performance across its segments. VITAS Healthcare achieved a revenue increase of 3.8%, but faced margin declines primarily due to sequestration cuts and higher staffing costs. Conversely, Roto-Rooter enjoyed a stronger performance with a revenue rise of 7.9%. Overall, Chemed is in a stable position with significant cash reserves and borrowing capacity, though challenges remain in their profit margins.
Read more →-CHE
Feb 23, 2023xFEFF; CONTACT: David P. William s (513) 762-6901  Chemed Reports Fourth-Quarter 2022 Results  CINCINNATI
Chemed Corporation reported its fourth-quarter results for 2022, showing mixed performance in its operations. The VITAS segment saw a 2.5% decline in net revenue, largely due to reductions in days-of-care and the reimplementation of sequestration cuts. In contrast, the Roto-Rooter segment showed growth with a 6.1% increase in revenue. The company forecasts revenue growth for VITAS and Roto-Rooter in 2023 but highlights challenges such as Medicare Cap billing limitations and rising operational costs.
Read more →-CHE
Oct 31, 2022xFEFF; CONTACT: David P. William s (513) 762-6901  Chemed Reports Third-Quarter 2022 Results – I ncreases 2022 Earnings Guidance  CINCINNATI
CONTACT: David P. Williams Chemed Reports Third-Quarter 2022 Results Increases 2022 Earnings Guidance CINCINNATI, October 31, 2022 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life
Read more →-CHE
Jul 27, 2022xFEFF; CONTACT: David P. William s (513) 762-6901  Chemed Reports Second-Quarter 2022 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports Second-Quarter 2022 Results CINCINNATI, July 27, 2022 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's
Read more →-CHE
Jun 29, 2022ITEM 99.1 Press Release for Amended Restated Credit Facility_Taxonomy2022    CONTACT: David P. Williams FOR IMMEDIATE RELEASE (513) 762-6901   Chemed Corporation Announces a Five-Y
CONTACT: David P. Williams FOR IMMEDIATE RELEASE (513) 762-6901 Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility CINCINNATI, June 29, 2022--Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into $
Read more →-CHE
Apr 26, 2022xFEFF; CONTACT: David P. William s (513) 762-6901  Chemed Reports First-Quarter 2022 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports First-Quarter 2022 Results CINCINNATI, April 26, 2022 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's
Read more →-CHE
Feb 24, 2022xFEFF; CONTACT: David P. William s (513) 762-6901  Chemed Reports Fourth-Quarter 2021 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports Fourth-Quarter 2021 Results CINCINNATI, February 24, 2022 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nati
Read more →-CHE
Oct 28, 2021xFEFF; CONTACT: David P. William s (513) 762-6901  Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased  CINCINNATI
CONTACT: David P. Williams Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased CINCINNATI, October 28, 2021 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of
Read more →-CHE
Jul 27, 2021David P. William s (513) 762-6901  Chemed Reports Second-Quarter 2021 Results – Full-Year 2021 Guidance Increased   CINCINNATI
CONTACT: David P. Williams Chemed Reports Second-Quarter 2021 Results Full-Year 2021 Guidance Increased CINCINNATI, July 27, 2021 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life c
Read more →-CHE
Apr 27, 2021David P. William s (513) 762-6901  Chemed Reports First-Quarter 2021 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports First-Quarter 2021 Results CINCINNATI, April 27, 2021 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's
Read more →-CHE
Feb 23, 2021David P. William s (513) 762-6901  Chemed Reports Fourth-Quarter 2020 Results   CINCINNATI
CONTACT: David P. Williams Chemed Reports Fourth-Quarter 2020 Results CINCINNATI, February 23, 2021 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nati
Read more →-CHE
Oct 29, 2020David P. William s (513) 762-6901  Chemed Reports Third-Quarter 2020 Results   CINCINNATI
CONTACT: David P. Williams Chemed Reports Third-Quarter 2020 Results CINCINNATI, October 29, 2020 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation
Read more →-CHE
Jul 29, 2020David P. William s (513) 762-6901  Chemed Reports Second-Quarter 2020 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports Second-Quarter 2020 Results CINCINNATI, July 29, 2020 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's
Read more →-CHE
Apr 28, 2020David P. William s (513) 762-6901   Chemed Reports First-Quarter 2020 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports First-Quarter 2020 Results CINCINNATI, April 28, 2020 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's
Read more →-CHE
Apr 22, 2020David P. Williams (513) 762-6901  Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting  CINCINNATI
CONTACT: David P. Williams Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting CINCINNATI, April 22, 2020--Chemed Corporation (NYSE:CHE) announced today that the Company will hold its 2020 Annual Meeting of Stockholders in a virtual-only format due to public he
Read more →-CHE
Mar 13, 2020David P. Williams (513) 762-6901  Chemed Corporation's Board of Directors Authorizes an Additional $250 Million for Stock Repurchase  CINCINNATI
CONTACT: David P. Williams Chemed Corporation's Board of Directors Authorizes an Additional $250 Million for Stock Repurchase CINCINNATI, March 13, 2020--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $250 millio
Read more →-CHE
Feb 18, 2020David P. William s (513) 762-6901   Chemed Reports Fourth-Quarter 2019 Results   CINCINNATI
CONTACT: David P. Williams Chemed Reports Fourth-Quarter 2019 Results CINCINNATI, February 18, 2020 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nati
Read more →-CHE
Oct 29, 2019David P. William s (513) 762-6901  Chemed Reports Third-Quarter 2019 Results  CINCINNATI
CONTACT: David P. Williams Chemed Reports Third-Quarter 2019 Results CINCINNATI, October 29, 2019 Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation
Read more →-CHE
Aug 5, 2019David P. Williams (513) 762-6901  Chemed Corporation Releases Updated Guidance  CINCINNATI
CONTACT: David P. Williams Chemed Corporation Releases Updated Guidance CINCINNATI, August 5, 2019---The VITAS and Chemed (NYSE:CHE) updated guidance includes the increase and rebasing of hospice reimbursement rates announced by CMS on July 31, 2019, and effective October 1, 20
Read more →-CHE
Jul 25, 2019Chemed Reports Second-Quarter 2019 Results CINCINNATI--(BUSINESS WIRE)
Chemed Reports Second-Quarter 2019 Results CINCINNATI--(BUSINESS WIRE)--July 25, 2019--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest
Read more →-CHE
Apr 29, 2019Chemed Reports First-Quarter 2019 Results CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2019 Results CINCINNATI--(BUSINESS WIRE)--April 29, 2019--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest comme
Read more →-CHE
Feb 25, 2019Chemed Corporation's Board of Directors Authorizes an Additional $150 Million for Stock Repurchase CINCINNATI--(BUSINESS WIRE)
Corporation's Board of Directors Authorizes an Additional $150 Million for Stock Repurchase CINCINNATI--(BUSINESS WIRE)--February 25, 2019--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $150 million for stock r
Read more →-CHE
Feb 20, 2019Chemed Reports Fourth-Quarter 2018 Results CINCINNATI--(BUSINESS WIRE)
Reports Fourth-Quarter 2018 Results CINCINNATI--(BUSINESS WIRE)--February 20, 2019--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest c
Read more →-CHE
Oct 29, 2018Chemed Reports Third-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI--(BUSINESS WIRE)
Reports Third-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI--(BUSINESS WIRE)--October 29, 2018--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Ro
Read more →-CHE
Oct 1, 2018Roto-Rooter Buys Five Northern California Franchises - Acquisition is the Company's Largest to Date CINCINNATI--(BUSINESS WIRE)
Buys Five Northern California Franchises - Acquisition is the Company's CINCINNATI--(BUSINESS WIRE)--October 1, 2018--Chemed Corporation ("Chemed") (NYSE:CHE) today announced its Roto-Rooter Services Company subsidiary has acquired five formerly independent Roto-Rooter franchi
Read more →-CHE
Jul 25, 2018Chemed Reports Second-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI--(BUSINESS WIRE)
Reports Second-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI--(BUSINESS WIRE)--July 25, 2018--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Root
Read more →-CHE
Jun 21, 2018Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CINCINNATI--(BUSINESS WIRE)
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CINCINNATI--(BUSINESS WIRE)--June 21, 2018--Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility ("
Read more →-CHE
Apr 19, 2018Chemed Reports First-Quarter 2018 Results CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2018 Results CINCINNATI--(BUSINESS WIRE)--April 19, 2018--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial an
Read more →-CHE
Feb 14, 2018Chemed Reports Fourth-Quarter 2017 Results CINCINNATI--(BUSINESS WIRE)
Reports Fourth-Quarter 2017 Results CINCINNATI--(BUSINESS WIRE)--February 14, 2018--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial
Read more →-CHE
Oct 31, 2017Chemed Settles DOJ Litigation No Admission or Determination of Wrongdoing CINCINNATI--(BUSINESS WIRE)
Chemed Settles DOJ Litigation No Admission or Determination of Wrongdoing CINCINNATI--(BUSINESS WIRE)--October 31, 2017--Chemed Corporation (Chemed) (NYSE: CHE), the parent company of VITAS Healthcare Corporation ("VITAS"), announced today that they have reached final agreement
Read more →-CHE
Oct 26, 2017Chemed Reports Third-Quarter 2017 Results -Increases Full-Year Guidance- CINCINNATI--(BUSINESS WIRE)
Reports Third-Quarter 2017 Results CINCINNATI--(BUSINESS WIRE)--October 26, 2017--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial a
Read more →-CHE
Jul 25, 2017Chemed Reports Second-Quarter 2017 Results -Earnings Guidance Increased- CINCINNATI--(BUSINESS WIRE)
Chemed Reports Second-Quarter 2017 Results -Earnings Guidance Increased- CINCINNATI--(BUSINESS WIRE)--July 25, 2017--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter,
Read more →-CHE
Apr 26, 2017Chemed Reports First-Quarter 2017 Results CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2017 Results CINCINNATI--(BUSINESS WIRE)--April 26, 2017--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and
Read more →-CHE
Mar 13, 2017Chemed Corporation's Board of Directors Authorizes an Additional $100 Million for Stock Repurchase CINCINNATI--(BUSINESS WIRE)
Corporation's Board of Directors Authorizes an Additional $100 Million for Stock Repurchase CINCINNATI--(BUSINESS WIRE)--March 13, 2017--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $100 million for stock repu
Read more →-CHE
Feb 15, 2017Chemed Reports Fourth-Quarter 2016 Results CINCINNATI--(BUSINESS WIRE)
Reports Fourth-Quarter 2016 Results CINCINNATI--(BUSINESS WIRE)--February 15, 2017--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial
Read more →-CHE
Oct 26, 2016Chemed Reports Third-Quarter 2016 Results CINCINNATI--(BUSINESS WIRE)
Reports Third-Quarter 2016 Results CINCINNATI--(BUSINESS WIRE)--October 26, 2016--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial a
Read more →-CHE
Jul 25, 2016Chemed Reports Second-Quarter 2016 Results -Raises Full-Year Earnings Guidance- CINCINNATI--(BUSINESS WIRE)
Reports Second-Quarter 2016 Results Full-Year Earnings Guidance- CINCINNATI--(BUSINESS WIRE)--July 25, 2016--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the n
Read more →-CHE
Jun 8, 2016Chemed Corporation Announces the Retirement of Timothy S. O'Toole CINCINNATI--(BUSINESS WIRE)
Corporation Announces the Retirement of Timothy S. O'Toole CINCINNATI--(BUSINESS WIRE)--June 8, 2016--After more than a decade of leading VITAS Healthcare Corporation to become the single largest hospice provider in America, Chief Executive Officer Timothy S. O'Toole has deci
Read more →-CHE
Apr 28, 2016Chemed Reports First-Quarter 2016 Results CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2016 Results CINCINNATI--(BUSINESS WIRE)--April 28, 2016--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and
Read more →-CHE
Feb 17, 2016Chemed Reports Fourth-Quarter 2015 Results CINCINNATI--(BUSINESS WIRE)
Reports Fourth-Quarter 2015 Results CINCINNATI--(BUSINESS WIRE)--February 17, 2016--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial
Read more →-CHE
Oct 22, 2015Chemed Reports Third-Quarter 2015 Results CINCINNATI--(BUSINESS WIRE)
Reports Third-Quarter 2015 Results CINCINNATI--(BUSINESS WIRE)--October 22, 2015--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial a
Read more →-CHE
Jul 23, 2015Chemed Reports Second-Quarter 2015 Results Increases 2015 Earnings Guidance CINCINNATI--(BUSINESS WIRE)
Reports Second-Quarter 2015 Results Increases 2015 Earnings Guidance CINCINNATI--(BUSINESS WIRE)--July 23, 2015--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, th
Read more →-CHE
Apr 28, 2015Chemed Reports First-Quarter 2015 Results CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2015 Results CINCINNATI--(BUSINESS WIRE)--April 28, 2015--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and
Read more →-CHE
Feb 17, 2015Chemed Reports Fourth-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)
Reports Fourth-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)--February 17, 2015--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial
Read more →-CHE
Oct 30, 2014Chemed Reports Third-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)
Reports Third-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)--October 30, 2014--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial a
Read more →-CHE
Jul 23, 2014Chemed Reports Second-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)
Reports Second-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)--July 23, 2014--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and
Read more →-CHE
Apr 29, 2014Chemed Reports First-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2014 Results CINCINNATI--(BUSINESS WIRE)--April 29, 2014--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and
Read more →-CHE
Feb 17, 2014Chemed Reports Fourth-Quarter 2013 Results CINCINNATI--(BUSINESS WIRE)
Reports Fourth-Quarter 2013 Results CINCINNATI--(BUSINESS WIRE)--February 17, 2014--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial
Read more →-CHE
Oct 28, 2013Chemed Reports Third-Quarter 2013 Results CINCINNATI--(BUSINESS WIRE)
Reports Third-Quarter 2013 Results CINCINNATI--(BUSINESS WIRE)--October 28, 2013--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial a
Read more →-CHE
Jul 18, 2013Chemed Reports Second-Quarter 2013 Results CINCINNATI--(BUSINESS WIRE)
Reports Second-Quarter 2013 Results CINCINNATI--(BUSINESS WIRE)--July 18, 2013--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and
Read more →-CHE
Apr 18, 2013Chemed Reports First-Quarter 2013 Results Reaffirms Full-Year 2013 Earnings Guidance CINCINNATI--(BUSINESS WIRE)
Reports First-Quarter 2013 Results Full-Year 2013 Earnings Guidance CINCINNATI--(BUSINESS WIRE)--April 18, 2013--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, th
Read more →-CHE
Feb 20, 2013Chemed Corporation's Board of Directors Authorizes an Additional $100 Million for Stock Repurchase - Declares Quarterly Dividend of 18 Cents CINCINNATI--(BUSINESS WIRE)
Corporation's Board of Directors Authorizes an Additional $100 Million for Stock Repurchase - Declares Quarterly Dividend of 18 Cents CINCINNATI--(BUSINESS WIRE)--February 20, 2013--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authori
Read more →Competitive Position
How CHE ranks across every disease it competes inCompetitive Position is a premium feature
See how CHE ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial